Search

Your search keyword '"Graham, Danielle L."' showing total 45 results

Search Constraints

Start Over You searched for: Author "Graham, Danielle L." Remove constraint Author: "Graham, Danielle L."
45 results on '"Graham, Danielle L."'

Search Results

1. Conceptualizing college-going volition in rural Appalachian high school students

2. Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial

3. Author Correction: Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial

4. Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial.

5. Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial

6. Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration

9. Author Correction: Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial

10. Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial

11. Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease

13. Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models

16. Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial

17. Trial of Cinpanemab in Early Parkinson’s Disease

19. Tau-targeting antisense oligonucleotide MAPTRxin mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial

21. Characterization of tau binding by gosuranemab

29. Author Correction: Tau-targeting antisense oligonucleotide MAPTRxin mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial

30. ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 × Ob1)F1 Mice by Induction of IL-10-Secreting iTregs

33. Environmental Enrichment Produces a Behavioral Phenotype Mediated by Low Cyclic Adenosine Monophosphate Response Element Binding (CREB) Activity in the Nucleus Accumbens

34. Tropomyosin-Related Kinase B in the Mesolimbic Dopamine System: Region-Specific Effects on Cocaine Reward

36. CREB regulation of nucleus accumbens excitability mediates social isolation–induced behavioral deficits

37. The Influence of ΔFosB in the Nucleus Accumbens on Natural Reward-Related Behavior

38. Molecular Adaptations Underlying Susceptibility and Resistance to Social Defeat in Brain Reward Regions

41. Overexpression ofCREB in the Nucleus Accumbens Shell Increases Cocaine Reinforcement in Self-Administering Rats.

42. Reinforcement-Related Regulation of AMPA Glutamate Receptor Subunits in the Ventral Tegmental Area Enhances Motivation for Cocaine.

43. Information-Rich, Dual-Function 13 C/ 2 H-Isotopic Crosstalk NMR Assay for Human Serine Racemase (hSR) Provides a PLP-Enzyme "Partitioning Fingerprint" and Reveals Disparate Chemotypes for hSR Inhibition.

44. Reinforcement-related regulation of AMPA glutamate receptor subunits in the ventral tegmental area enhances motivation for cocaine.

45. The influence of DeltaFosB in the nucleus accumbens on natural reward-related behavior.

Catalog

Books, media, physical & digital resources